1. We have developed methods that yield estimates of the 32p content of each of the individual phosphate groups of phosphatidylinositol 4-phosphate and phosphatidylinositol 4,5-bisphosphate, thus extending the information available from studies of the labelling of these lipids in intact cells or membrane preparations. The analyses are undertaken with the deacylated lipids. 2. Assay of the 5-phosphate of phosphatidylinositol 4,5-bisphosphate is achieved by the use, under conditions of first-order kinetics, of a 5-phosphate-specific phosphomonoesterase present in isolated erythrocyte membranes [Downes, Mussat & Michell (1982) Biochem. J. 203,[169][170][171][172][173][174][175][176][177]. 3. Assay of the 4-phosphate of phosphatidylinositol 4-phosphate and of the total monoester phosphate content (4-phosphate plus 5-phosphate) of phosphatidylinositol 4,5-bisphosphate employs alkaline phosphatase from bovine intestine. The radioactivity of the 1-phosphate is that remaining as organic phosphate after exhaustive alkaline phosphatase treatment. 4. The methodology has been validated by using lipids from human erythrocytes: these contain no 32p in their 1-phosphate. 5. These methods should be of substantial value in studies of the many cells that show rapid hormonal perturbations of phosphatidylinositol 4,5-bisphosphate metabolism.
Polyphosphoinositides (PtdIns4P and PtdIns4, 5P2) are present in tissues at low concentrations but rapidly incorporate 32p, particularly into their monoester phosphate groups. Their metabolism can be dramatically perturbed by hormones and neurotransmitters, but neither the mechanism nor the function of these changes is yet understood (see , for a review).
Metabolic turnover of the entire inositol 1,4-bisphosphate and inositol 1,4,5-trisphosphate headgroups of PtdIns4P and Ptdlns4,5P2 involves a minimum of ten enzymic steps (see Scheme 1) and yet 32P-labelling studies do not usually distinguish between the individual phosphate groups in each lipid molecule. It is usually assumed that the monoesterified 4-phosphate and 5-phosphate groups of these lipids are much more metabolically active than the diesterified 1-phosphate, and that subAbbreviations used, PtdIns4P and PtdIns4,5P2, phosphatidylinositol 4-phosphate and 4,5-bisphosphate respectively; Hepes, 4-(2-hydroxyethyl)-}-piperazineethane sulphuric acid. stantial changes in 32P-labelling reflect changes only in the monoesterified phosphate groups. Occasionally this has been verified by the use of an unspecific phosphomonoesterase to distinguish between monoesterified and diesterified phosphate groups (Brockerhoff & Ballou, 1962; Hokin & Hokin, 1964; Galliard et al., 1965) .
Ideally, studies of these lipids would employ simple, routine techniques that would allow a separate analysis of each of the phosphate groups in the PtdIns4P and PtdIns4,5P2 molecules. Some years ago, Prottey et al. (1968) demonstrated that intestinal alkaline phosphatase and wheat bran phytase showed slight specificity for the 4-phosphate and 5-phosphate, respectively, of deacylated PtdIns4,5P2. However, the discrimination achieved in this study was not sufficient for the adoption of these enzymes as routine analytical tools. Recently we have described an inositol 1,4,5-trisphosphate 5-phosphomonoesterase that will attack deacylated PtdIns4,5P2, leading to selective release of its 5-phosphate 
Materials and methods
Materials were, unless otherwise noted, of the types and from the sources specified previously (Downes & Michell, 1981; . Bovine intestinal alkaline phosphatase was from Sigma (type P 5521). Folch fraction I/JI (a polyphosphoinositide-rich lipid fraction from brain) was prepared as described by Folch (1949) .
Protein was estimated according to Lowry et al. (1951) using bovine serum albumin as standard. ATP concentrations were estimated by using an assay linked to the production of NADPH (Lamprecht & Trautschold, 1974) . Total phosphorus was assayed after wet digestion with HC104 as described by Galliard et al. (1965) . The Pi released during enzymic degradation of samples was measured by the method of Baginski et al. (1967 32P-labelled glycerophosphoinositol 4-phosphate and glycerophosphoinositol 4,5-bisphosphate were derived from 32P-labelled PtdIns4P and Ptdlns4,5P2 of erythrocytes. Packed human erythrocytes (3-4ml) were incubated at 60% haematocrit with 1 mCi of [32P]P, for 120 min, as described by . 32P-labelled membranes were isolated and used both for the preparation of glycerophosphoinositol 4-phosphate and glycerophosphoinositol 4,5-bisphosphate Creba et al., 1983) and, via activation of the endogenous polyphosphoinositide phosphodiesterase, for the generation of inositol 1,4-bisphosphate and inositol 1,4,5-trisphosphate . The ammonium formate eluates in which these esters were obtained from the resin columns were neutralized with ammonium hydroxide and they were stored at -20°C. When more concentrated, salt-free samples of the esters were required, the ammonium formate was removed by freeze-drying and the esters were redissolved in a small volume of water (pH adjusted to 7.0 with cyclohexylamine).
32P-labelled inositol 1,4,5-trisphosphate was also prepared by chemical degradation of isolated 32P-labelled glycerophosphoinositol 4,5-bisphosphate by the method of Brown & Stewart (1966 (Downes & Michell, 1981) .
Isolation ofhuman erythrocyte membranes for use as inositol 1,4,5-trisphosphatase 5-phosphomonoesterase
The membranes were isolated as described by . They were divided into small samples and stored at -20°C until required. A volume of 250ml of packed erythrocytes yields approx. 80ml of membranes at a protein concentration of 5-6mg/ml. This is sufficient for about 100 determinations of the 5-phosphate of glycerophosphoinositol 4,5-bisphosphate.
Selective release of the 5-phosphate from glycerophosphoinositol 4,5-bisphosphate Samples (0.5 ml) of 32P-labelled glycerophosphoinositol 4,5-bisphosphate in 0.85M-ammonium formate (from neutralized column eluates, see above) were diluted to 5ml with Hepes buffer (30mM, pH7.2) and 2mM-MgCl2 and erythrocyte membranes were added to a final concentration of approx. 1.Omg of protein/ml. Unless otherwise specified, incubations were at 37°C for 75min, during which time the kinetics of breakdown were first-order, leading to hydrolysis of 40-60% of the 5-phosphate. Reactions were terminated and the proportion of total 32P released as [32P]P, was determined as described below. The precise extent of breakdown was calibrated by using a sample of erythrocyte glycerophosphoinositol 4,5-bisphosphate in which the proportion of 32P in the 5-phosphate had been previously determined (see the Results and discussion section).
Analysis of the reaction products from incubation of glycerophosphoinositol 4,5-bisphosphate and inositol 1,4,5-trisphosphate with erythrocyte ghosts Samples of the labelled phosphate esters were incubated with erythrocyte membranes as described above, except that the incubation volume was 1Oml. Reactions were terminated with 5ml of ice-cold lOmM-EDTA, pH7.0. The membranes were removed by centrifugation at lOOOOg for 15min and the supernatants were freeze-dried until most of the ammonium formate had sublimed. The freeze-dried residue was dissolved in lOml of 5 mM-disodium tetraborate (the resulting pH was approx. 7.0) and applied to a column (4cm x 0.6cm) of. Dowex-1 (100-200 mesh; formate form). The reaction products were separated as described (Downes & Michell, 1981; Creba et al., 1983) .
Selective release ofthe 4-phosphatefrom glycerophosphoinositol 4-phosphate Samples (0.5 ml) of 32P-labelled glycerophosphoinositol 4-phosphate in 0.4M-ammonium formate (from the neutralized column eluates, see above) were diluted to 1 ml with ethanolamine buffer (20mM, pH9.5), 5mM-MgCl2 and approx. 0.02 units of bovine intestinal alkaline phosphatase. Incubations were at 37°C for 2h, during which time glycerophosphoinositol 4-phosphate was quantitatively converted to glycerophosphoinositol and P1 (see the Results and discussion section). Incubations were terminated and the proportion of total 32P released as [32p]p; was assayed as described below.
Selective release of the 4-and 5-phosphates from glycerophosphoinositol 4,5-bisphosphate
This was achieved in a very similar manner to that described for the release of the 4-phosphate from glycerophosphoinositol 4-phosphate, except that more alkaline phosphatase was required. Samples (0.235 ml) of 32P-labelled glycerophosphoinositol 4,5-bisphosphate were assayed in place of 0.5 ml samples of glycerophosphoinositol 4-phosphate (so that the final concentration of ammonium formate was approx. 0.2M in each case) and approx. 0.6 units/ml of alkaline phosphatase were present so as to achieve quantitative conversion of glycerophosphoinositol 4,5-bisphosphate to glycerophosphoinositol and Pi within 2h (see the Results and discussion section)
Measurement of 32P-labelled Pi released during enzymic degradation ofphosphate esters
The method is based on that of Martin & Doty (1949) . Incubations were terminated by the addition of ice-cold HC104 to a final concentration of 1 M. After centrifugation to remove protein, a sample of the supernatant was taken and ammonium molybdate was added to a final concentration of 1% (w/v). Two volumes of isobutyl alcohol/toluene (1:1, v/v) were added and the samples were mixed vigorously. The two phases were separated by centrifugation and a sample of the upper phase was dispensed into 3 vol. of Triton/toluene scintillation fluid and its radioactivity determined. When alkaline phosphatase was used, the protein concentration was so low that the first centrifugation step could be safely omitted.
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Results and discussion Selective chemical or enzymic methods for the analysis of the individual phosphate groups of PtdIns4P and PtdIns4,5P2 might in principle be applied either to the intact lipids or to some isolated portion of these molecules. Both approaches are practical possibilities, since recent reports have described both a PtdIns4,5P2 5-phosphomonoesterase (Roach & Palmer, 1981) and an inositol 1,4,5-trisphosphate 5-phosphomonoesterase that also degrades glycerophosphoinositol 4,5-bisphosphate (Downes & Michell, 1981; .
We chose to develop selective degradation procedures applicable to the water-soluble phosphate esters produced by alkaline deacylation of the lipids, rather than to the intact lipids, for two reasons. First, degradation of these water-soluble phosphate esters by added enzymes would occur in an homogenous aqueous phase, and would not involve the uncertainties of enzyme access that are implicit in enzyme attack upon dispersed lipid substrates. Secondly, we have recently made extensive use of Dowex-1 anion-exchange columns for separating the deacylation products of PtdIns4P and Ptdlns4,5P2 derived from intact cells (Downes & Michell, 1981 Creba et al., 1983) , so these esters were readily available in a form suitable for analysis. They are normally present in the eluates from Dowex 1 columns at very low concentrations and in a medium of quite high ionic strength. For Validation of the specific removal of the S-phosphate from glycerophosphoinositol 4,5-bisphosphate concluded that the inositol 1,4,5-trisphosphate phosphomonoesterase of erythrocyte membranes selectively removed the 5-phosphate from both inositol 1,4,5-trisphosphate and glycerophosphoinositol 4,5-bisphosphate. For the former compound this conclusion was based on a rigorous demonstration of the liberation of a para isomer of inositol bisphosphate (i.e. of inositol 1,4-bisphosphate rather than the 1,5-or 4,5-isomers), but no equally simple approach was available for glycerophosphoinositol 4,5-bisphosphate. In that case, therefore, we made use of the fact that 32p iS unequally distributed between the 4-and 5-phosphate of Ptdlns4,5P2 extracted from erythrocytes that have been incubated with [32P]Pi for 2h. We demonstrated that the distribution of radioactivity between organic and inorganic phosphate amongst the products of phosphomonoesterase attack upon inositol 1,4,5-trisphosphate and upon glycerophosphoinositol 4,5-bisphosphate were the same (provided that both esters were isolated from the same erythrocyte ghosts, and hence from the same PtdIns4,5P2).
Since the key step in the procedure to be described below is the use of the erythrocyte membrane inositol trisphosphate phosphomonoesterase to remove the 5-phosphate from glycerophosphoinositol 4,5-bisphosphate, we initially sought to confirm more rigorously the specificity of its attack on the 5-phosphate of this ester. In order to do this we isolated from the same batch of erythrocyte ghosts: (a) glycerophosphoinositol 4,5-bisphosphate derived from PtdIns4,5P2 by alkaline methanolysis; (b) inositol 1,4,5-trisphosphate derived from this glycerophosphoinositol 4,5-bisphosphate by chemical degradation (Brown & Elution volume (ml) Fig. 2 (1982) .
The rate of hydrolysis of glycerophosphoinositol 4,5-bisphosphate by erythrocyte ghosts was proportional to substrate concentration at least up to 1O gM (Fig. 3) . This implies-that hydrolysis of this ester should be a first-order process at the very low glycerophosphoinositol 4,5-bisphosphate concentrations present in the eluates from Dowex columns. This was found to be so (Fig. 4) .
In the study by , it was noted, using a substrate concentration that was approximately 2x Km for inositol 1,4,5-trisphosphate, that glycerophosphoinositol 4,5-bisphosphate was attacked about one-eighth as fast as inositol 1,4,5-trisphosphate. Under the conditions of first-order degradation chosen for routine analytical use of this enzyme this disparity was even greater. The half-lives of inositol 1,4,5-trisphosphate and glycerophosphoinositol 4,5-bisphosphate under these conditions were 2.5-3.0min and 60-75min, respectively (Fig. 4) ; i.e. the firstorder rate constants differed by about a factor of 30.
The simplest way to apply the inositol trisphosphate phosphatase to the analysis of the 5-phosphate of glycerophosphoinositol 4,5-bisphosphate would be to incubate for a period long enough to achieve essentially complete breakdown. However, this would take many hours (e.g. approx. 7 h for 98% hydrolysis). This was not feasible since during such prolonged incubations the erythrocyte ghost preparation released a small amount of radioactivity from inositol 1,4-bisphosphate and glycerophosphoinositol 4-phosphate (Fig. 4) . This activity against the diphosphate esters is probably independent of the activity against inositol 1,4,5-trisphosphate and glycerophosphoinositol 4,5-bisphosphate, since it exhibits a different sensitivity to various inhibitors (Zn2 , Cd2 , Ag+ and F-; P. T. Hawkins & C. E. King, unpublished work). However, we have not found an inhibitor that shows sufficient discrimination to eliminate selectively this phosphatase in routine use.
The general characteristics of the inositol trisphosphate 5-phosphomonoesterase were described by . We have noted two additional properties that facilitate its routine use as an analytical tool. It is stable during storage of erythrocyte membranes at -20°C for several weeks, and its activity is almost undiminished in the presence of ammonium formate at concentrations up to approx. 0.1 M. This latter property 1984 facilitates its application to the analysis of phosphate esters in diluted eluates from Dowex 1 anion exchange columns. In order to check for possible variability of the phosphatase activity of different ghost preparations, we isolated ghosts from erythrocytes of a variety of blood groups, both within a day or two of donation and after becoming outdated by three weeks of storage for transfusion. No systematic variations were observed: the firstorder rate constants for attack upon glycerophosphoinositol 4,5-bisphosphate under our standard incubation conditions (approx. 1mg of protein/ml) were (5.98 + 0.4) x 10-3min-1 (mean + S.E.M. for ten separate ghost preparations). Calibration of the assay ofS-phosphate release from glycerophosphoinositol 4,5-bisphosphate by erythrocyte ghosts When a series of samples are all incubated identically under conditions giving first-order breakdown then exactly the same proportion of the substrate will be degraded in every sample. We therefore chose to incubate all glycerophosphoinositol 4,5-bisphosphate samples under conditions which achieved 40-60% hydrolysis of the 5-phosphate (the exact figure was in each case dependent on the activity of the particular erythrocyte ghost preparation), with negligible attack on the 4-phosphate. The precise extent of this hydrolysis was determined by assaying in parallel the extent of hydrolysis of a 'standard' sample of glycerophosphoinositol bisphosphate.
In order to prepare and calibrate this 'standard' sample, samples of labelled inositol 1,4,5-trisphosphate and glycerophosphoinositol 4,5-bisphosphate were isolated from one batch of erythrocytes that had been incubated with [32P]P, for 2h (see the Methods section). Such samples usually have 60-70% of their 32P in the 5-phosphate (see above). A sample of inositol trisphosphate was then incubated under conditions leading to complete removal of the 5-phosphate without attack on the 4-phosphate (Fig. 1) , thus defining precisely the distribution of 32P between the 4-and 5-phosphates of this ester and of the glycerophosphoinositol 4,5-bisphosphate (see above).
A sample of such a 'standardized' preparation of -glycerophosphoinositol 4,5-bisphosphate was included in every experimental determination of 5-phosphate release as applied to diluted column eluates. This-yielded a value for the fraction of the total 5-phosphate released from the 'standard' sample; this correction factor was used to convert the value of released radioactivity for each unknown sample to a value of the total radioactivity in the 5-phosphate.
We have routinely used 32P-labelled glycerophosphoinositol 4,5-bisphosphate from erythrocytes for calibrating our assays: this is easily prepared from erythrocyte ghosts at high specific radioactivity, but its radioactivity decays with a half-life of only 14 days. In principle, it would also be possible to use glycerophosphoinositol 4,5-bisphosphate prepared from Ptdlns4,5P2 that had been labelled with [3H] inositol for this purpose.
This would be stable during prolonged storage, so avoiding the need to prepare frequently fresh batches of 'standard' glycerophosphoinositol 4,5-bisphosphate. However, its use would also entail some disadvantages: (1) it would be expensive to prepare in substantial quantities at high specific radioactivity; and (2) Time (min) Fig. 6 . Selective release of the 4-and 5-phosphates from glycerophosphoinositol 4,5-bisphosphate by alkaline phosphatase Samples of 32P-labelled and unlabelled glycerophosphoinositol 4,5-bisphosphate (derived from erythrocytes and Folch fraction I/II respectively) were incubated together with alkaline phosphatase (5 units/ml) as described in the Materials and methods section. At various times, aliquots of the incubation were taken for analysis of the 32P-labelled (-) and unlabelled (Ol) (Fig. 6) . As with glycerophosphoinositol 4-phosphate, the routine assay conditions chosen incorporate a large margin of safety over the minimum enzyme concentration and incubation period needed to yield quantitative degradation.
Strategy used for enzyme degradation of PtdIns4P and PtdIns4,5P2 This is summarized in Scheme 2. A complete description of the distribution of 32P between the 1-phosphate and 4-phosphate of PtdIns4P can be obtained simply by the application of alkaline phosphatase, whereas a complete description of the distribution of radioactivity between the three phosphates of PtdIns4,5P2 can only be obtained by treating separate samples of the labelled glycerophosphoinositol 4,5-phosphate with alkaline phosphatase and erythrocyte ghosts and then combining the results.
